No results for ‘’
Panchsheel Organics Ltd
₹125.10
(4.12%)
Wed, 17 Jun 2026, 06:01 am
Health Technology
Pharmaceuticals: Major
24.5KPanchsheel Organics EV/EBITDA Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 4.48 | 9.31 | 12.27 | 4.70 | 9.49 | 6.68 | 9.76 | 13.26 | 17.98 | 9.07 | 8.32 | 3.25 | 8.51 | 18.37 | 14.49 | 18.22 | 12.90 |
| Price to book ratio | 0.27 | 0.66 | 0.63 | 0.55 | 0.79 | 0.71 | 1.05 | 1.93 | 2.42 | 1.24 | 1.10 | 0.49 | 1.07 | 3.24 | 2.12 | 1.84 | 1.33 |
| Price to sales ratio | 0.15 | 0.37 | 0.33 | 0.29 | 0.36 | 0.30 | 0.52 | 1.01 | 1.44 | 0.79 | 0.70 | 0.34 | 0.86 | 2.22 | 1.98 | 2.44 | 1.66 |
| Price to cash flow ratio | 8 | 0 | 0 | 21.96 | 173.94 | 4.23 | 17.23 | 8.71 | 79.80 | 12.93 | 15.72 | 3.81 | 8.49 | 0 | 301.83 | 21.86 | 27.25 |
| Enterprise value | 6.95Cr | 12.77Cr | 14.12Cr | 13.67Cr | 18.1Cr | 16.53Cr | 23.77Cr | 44.44Cr | 64.06Cr | 38.66Cr | 37.89Cr | 19.87Cr | 41.89Cr | 156Cr | 206Cr | 241Cr | 179Cr |
| Enterprise value to EBITDA ratio | 0.31 | 6.11 | 6.36 | 4.35 | 5.19 | 3.70 | 3.70 | 7.87 | 9.59 | 5.50 | 5.38 | 2.30 | 4.86 | 11.79 | 10.30 | 12.17 | 10.17 |
| Debt to equity ratio | 0.33 | 0.35 | 0.47 | 0.36 | 0.43 | 0.33 | 0.38 | 0.23 | 0.28 | 0.21 | 0.16 | 0.12 | 0.09 | 0.09 | 0.06 | 0.05 | 0.04 |
| Return on equity % | 0 | 7.30 | 5.28 | 12.37 | 8.23 | 11.05 | 11.07 | 15.77 | 14.35 | 14.57 | 14.05 | 16.08 | 13.35 | 19.19 | 19.61 | 12.76 | 10.66 |
Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio
The Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Panchsheel Organics Ltd's valuation, profitability, and overall financial performance. Tracking the Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Panchsheel Organics Ltd (NSE: PANCHSHEEL, BSE: 531726) is currently trading at ₹125.10, with a market capitalization of ₹160.23Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio Current Value
The current Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio stands at 10.17.
The Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 10.17
- 2023: 12.17
- 2022: 10.30
- 2021: 11.79
- 2020: 4.86
The decline in Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Panchsheel Organics Ltd.
Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Panchsheel Organics Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.